Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-26-002094
Filing Date
2026-04-22
Accepted
2026-04-22 11:53:50
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8253
  Complete submission text file 0000902664-26-002094.txt   10059
Mailing Address 7/F, K11 ATELIER, 728 KING'S ROAD QUARRY BAY K3 000000
Business Address 7/F, K11 ATELIER, 728 KING'S ROAD QUARRY BAY K3 000000 (852) 2210-7188
Prenetics Global Ltd (Subject) CIK: 0001876431 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93679 | Film No.: 26882231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 7B YARDLEY COMMERCIAL BUILDING 3 CONNAUGHT ROAD WEST SHEUNG WEN, HONG KONG SAR K3
Business Address 7B YARDLEY COMMERCIAL BUILDING 3 CONNAUGHT ROAD WEST SHEUNG WEN, HONG KONG SAR K3 (852) 2526 1833
Genetel Bioventures Ltd (Filed by) CIK: 0001943105 (see all company filings)

EIN.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A